Pancreatic cancer halted by virus injection in three patientsImage: scienceinhand.com
Cooling

Pancreatic cancer halted by virus injection in three patients

Heat 58 · #6 in Science · Cooling4 reports · 4 sources · First reported May 2026 · Updated Nov 20

The story

An engineered virus injected directly into tumours has halted the progression of inoperable pancreatic cancer in three patients in a University of Minnesota Phase I trial. The treatment uses a genetically engineered adenovirus, RGDCRAdCOX2F (trial NCT06693986), and all three patients were still alive with stable disease more than six months after treatment; in the fall 2026 follow-up, one had reached 15 months of disease control. The findings were presented at the ASGCT meeting in May 2026. The caveats are substantial: the trial involved only three patients, had no control group, and the results have not yet appeared as a full peer-reviewed paper. 'Halted' here means stable disease — the cancer stopped growing — not a cure or tumour shrinkage.
Latest development
no keepalive from any source this round (no Lobsters/Techmeme/YouTube trace)

How it unfolded

  1. no keepalive from any source this round (no Lobsters/Techmeme/YouTube trace)
  2. REVIVAL per round-35 rule - restore formula score, clear cooling, composite 58.0->78.0
  3. Nov 20, 23:16
    own HN post 50563066 back in top 30 at #30, 840 pts/145 cmt
  4. no keepalive from any source this round
  5. composite restored to formula 78.0 (h60, d100, x70)
  6. Nov 20, 19:35
    own HN post 50563066 BACK in top 30 at #22, 792 pts/137 cmt - REVIVAL per the round-218 precedent (own post returns)
  7. no Lobsters/Techmeme/YouTube trace this round - cooling, composite 78.0->58.0
  8. caveats: three patients only, no control group, findings presented at ASGCT (May 2026) not a full peer-reviewed paper, 'halted' means stable disease, not cure or tumour shrinkage
  9. University of Minnesota Discovery magazine, fall 2026
  10. scienceinhand.com write-up of a University of Minnesota Phase I trial: a genetically engineered adenovirus (RGDCRAdCOX2F, NCT06693986) injected into tumours halted progression in three people with inoperable pancreatic cancer - all three alive with stable disease past six months, one reached 15 months of disease control in the fall 2026 follow-up (first reported June 2026)

The angle

A modified cold virus stopped pancreatic cancer from growing in three patients - at a tenth of the planned doseSuggested format: Short video · for General audience, health and science readers

Heat

Now 58 · Peak 84 · 64 recorded checks since Nov 20
Full ranking →